Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.
about
Phosphorylation of NFATc4 by p38 mitogen-activated protein kinasesPPARs and the cardiovascular systemCell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old playerLiver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunityActivation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3Requirement of two NFATc4 transactivation domains for CBP potentiationThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesPeroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritisPPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.PPARγ negatively regulates T cell activation to prevent follicular helper T cells and germinal center formation.Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance.Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells).Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity.Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity.Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseasePPAR and immune system--what do we know?PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effectPPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibitionAnalysis of transcription factor network underlying 3T3-L1 adipocyte differentiation.Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane diseaseNovel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists.Haploinsufficiency for Stard7 is associated with enhanced allergic responses in lung and skin.PPARgamma as a new therapeutic target in inflammatory bowel diseasesThe Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasiaTranscriptional regulation of T cell tolerance.PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases.PPARs in alveolar macrophage biology.Nuclear receptors as modulators of the tumor microenvironment.15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
P2860
Q24537383-C047AF03-7CDD-4BE7-886A-77CACF6D5D43Q24642728-2E9C63D6-4DE3-489C-8AD1-9129702C75CEQ26751243-167DA23B-A450-4415-A8A4-B51C523A26D0Q27013011-E17151E9-33D1-4EDE-9599-33A259B6005BQ28204011-702E80EA-E722-4BAF-8FA9-90E3A77DEF5CQ28213900-7E859214-9CFB-4E48-863E-5E07C10FD448Q28238709-4D624A37-9DC9-4A32-A560-319CC8968153Q28365786-5FE50A8A-8D0C-41D6-B182-5F240DDB6CDEQ28574163-020116F0-78B8-4C47-9695-8AA2A9E4EB42Q30700375-031F7FB8-EB43-4563-9F54-E05F5476177EQ33644094-B6B2ED50-8992-4796-BB14-383058BA9ADEQ33748674-E444E8D8-34D4-46B2-9526-0958BB2F573CQ34024668-382F7957-8E3A-489E-A5E5-E24FB66A2BE1Q34038532-0B008655-532A-43F3-ABBA-D76C953CF3D0Q34185316-91752C9E-B29C-4385-A5A6-04A91082A2C1Q34222727-28AEA1B4-1CE0-427C-9631-E53AFF05BA3AQ34460512-655C645D-96BF-441F-B43A-73F7501D3643Q34509964-2E6A6B6F-DBC9-4A56-9C01-32BABF8ED306Q34580424-17887AB9-65DC-48FA-8BCC-CF8AB842A002Q34597051-A27BBC54-2B34-471A-8297-29CE0EAD8974Q34804346-1F86DD5C-8057-48DB-97F2-4FFA63C2FBFDQ34913467-EA7D335B-A4A9-43E7-8CCA-4FDAC65F05A8Q35045267-AC6382FC-326A-4DA2-9E8B-2E7C67BE24F4Q35053566-4C060502-878C-4DA8-ACFB-57200E61E5D8Q35080524-45123039-C831-4B08-996D-18512627ED36Q35164566-DD525ED6-3F1A-4015-A0EA-EBABDBC02D50Q35215616-4A9195F3-DDBF-4E68-BB05-4F748FFD07DEQ35293454-08F3E95D-7326-4F0C-A37C-96E130D53BE2Q35371579-0061F7D4-67C4-4B52-BDF9-9B9FA37F0736Q35557407-D3965942-866B-4838-8C44-5F3DE20304E8Q35673358-2B40454F-FFA9-4664-8663-EDE921C52303Q35691045-C59C1257-2E5D-4981-9108-148189143E50Q35768913-F3FFB875-2C0C-469E-B246-735D6D5E2B49Q35788899-52A65C57-93AB-4531-8A2B-1C4DC9A39616Q35943219-1AE57066-8FD9-41A5-8B31-ECE6ACA95470Q35995040-75B23241-C381-4C3B-97BB-6A47EAEBF5CEQ36065220-42805E8D-9508-4AD8-BADB-AB5D673D5447Q36121727-8C290F39-9815-4702-97C3-29F2254596B6Q36127288-F942BD96-0AD5-4EF0-8FEC-554910748B92Q36174169-EA3280BB-9D64-4D8E-94B5-12008287EFAC
P2860
Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Activation of human T lymphocy ...... ith transcription factor NFAT.
@en
type
label
Activation of human T lymphocy ...... ith transcription factor NFAT.
@en
prefLabel
Activation of human T lymphocy ...... ith transcription factor NFAT.
@en
P2093
P356
P1476
Activation of human T lymphocy ...... ith transcription factor NFAT.
@en
P2093
P304
P356
10.1074/JBC.275.7.4541
P407
P577
2000-02-01T00:00:00Z